메뉴 건너뛰기




Volumn 28, Issue 12, 2009, Pages 1361-1374

A randomized double-blind study comparing the efficacy and safety of orlistat versus, placebo in obese patients with mild to moderate hypercholesterolemia;Estudo comparativo, aleatorizado, em dupla ocultação, de orlistat versus placebo, de eficácia e segurança, em doentes obesos com hipercolesterolemia ligeira a moderada

(19)  De Castro, João Jácome a   Dias, Teresa b,j   Chambel, Paula a   Carvalheiro, Manuela c   Correia, Luís Gardette d   Guerreiro, Liliana c   Marques, Olinda f   Medina, José Luís g   Nobre, E M A b,j   Nunes, José Silva d   Pereira, Maria Carlos h   Polónia, Jorge g   Portugal, Jorge h   Raimundo, Anabela i   Ruas, Almeida c   Da Silva, Pedro Marques i   Vasconcelos, Carlos e   Reis, José Lima g   Teles, Alberto Galvão b  

c HUC   (Portugal)

Author keywords

Dyslipidemia; Hypercholesterolemia; Obesity; Orlistat

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL;

EID: 77349084863     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (30)
  • 1
    • 77349109163 scopus 로고    scopus 로고
    • Health and Fitness Survey; Dublin: Institute of European Food Studies 2000
    • Health and Fitness Survey; Dublin: Institute of European Food Studies 2000
  • 2
    • 0004318660 scopus 로고    scopus 로고
    • Obesity. Preventing and managing the global epidemic
    • Obesity. Preventing and managing the global epidemic. Report of a WHO Consultation on obesity, 1997
    • (1997) Report of a WHO Consultation on obesity
  • 3
    • 77349116032 scopus 로고    scopus 로고
    • National Health Examination Surveys
    • National Health Examination Surveys. Endocrinol Metab Clin N Am 2003.
    • (2003) Endocrinol Metab Clin N Am
  • 5
    • 9644254084 scopus 로고    scopus 로고
    • Tendências do peso em Portugal no final do século XX.
    • Lacerda Nobre E, Macedo JA, Castro J. Tendências do peso em Portugal no final do século XX. Acta Med Port 2004; 17 205-9.
    • (2004) Acta Med Port , vol.17 , pp. 205-209
    • Lacerda Nobre, E.1    Macedo, J.A.2    Castro, J.3
  • 6
    • 0027966932 scopus 로고
    • Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
    • Chan JM, Rimm EB, Colditz GA et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961-9.
    • (1994) Diabetes Care , vol.17 , pp. 961-969
    • Chan, J.M.1    Rimm, E.B.2    Colditz, G.A.3
  • 7
    • 0028917432 scopus 로고
    • Weight gain as a risk factor for clinical diabetes mellitus in women
    • Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-6.
    • (1995) Ann Intern Med , vol.122 , pp. 481-486
    • Colditz, G.A.1    Willett, W.C.2    Rotnitzky, A.3    Manson, J.E.4
  • 8
    • 0030989520 scopus 로고    scopus 로고
    • Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study
    • Carey VJ, Walters EE, Colditz GA et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997;145:614-9.
    • (1997) Am J Epidemiol , vol.145 , pp. 614-619
    • Carey, V.J.1    Walters, E.E.2    Colditz, G.A.3
  • 9
    • 0022402245 scopus 로고
    • Health implication of overweight and obesity in the United States
    • Van Itallie TB. Health implication of overweight and obesity in the United States. Ann Int Med. 1985;103:983-8
    • (1985) Ann Int Med , vol.103 , pp. 983-988
    • Van Itallie, T.B.1
  • 10
    • 0022379345 scopus 로고
    • Overweight and cancer
    • Garfinkel L. Overweight and cancer. Ann Int Med. 1985;103: 1047-52.
    • (1985) Ann Int Med , vol.103 , pp. 1047-1052
    • Garfinkel, L.1
  • 13
    • 0033533859 scopus 로고    scopus 로고
    • Body-mass index and mortality in a prospective cohort of US adults
    • Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341:1097-105.
    • (1999) N Engl J Med , vol.341 , pp. 1097-1105
    • Calle, E.E.1    Thun, M.J.2    Petrelli, J.M.3
  • 14
    • 0032742418 scopus 로고    scopus 로고
    • The disease burden associated with overweight and obesity
    • Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999; 282:1523-9.
    • (1999) JAMA , vol.282 , pp. 1523-1529
    • Must, A.1    Spadano, J.2    Coakley, E.H.3
  • 15
    • 0029012215 scopus 로고
    • The primary prevention of coronary heart disease in women
    • Rich-Edwards JW, Manson JE, Hennekens CH et al. The primary prevention of coronary heart disease in women. N Eng J Med 1995;332:1758-66
    • (1995) N Eng J Med , vol.332 , pp. 1758-1766
    • Rich-Edwards, J.W.1    Manson, J.E.2    Hennekens, C.H.3
  • 16
    • 27644457743 scopus 로고    scopus 로고
    • Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: A case-control study
    • Yusuf S, Hawken S, Ôunpuu S et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9
    • (2005) Lancet , vol.366 , pp. 1640-1649
    • Yusuf, S.1    Hawken, S.2    Ôunpuu, S.3
  • 17
    • 30444456396 scopus 로고    scopus 로고
    • Midlife body mass index and hospitalization and mortality in older age
    • Yan LL, Daviglus ML, Liu K et al. Midlife body mass index and hospitalization and mortality in older age. JAMA, 2006; 295:190-8
    • (2006) JAMA , vol.295 , pp. 190-198
    • Yan, L.L.1    Daviglus, M.L.2    Liu, K.3
  • 18
    • 77349126966 scopus 로고    scopus 로고
    • The IDF consensus worldwide definition of the metabolic syndrome April
    • The IDF consensus worldwide definition of the metabolic syndrome April 2005. www.idf.org
    • (2005)
  • 19
    • 0032543870 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
    • for the European Multicentre Orlistat Study Group
    • Sjöstron L, Rissanen A, Andersen T, for the European Multicentre Orlistat Study Group. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet. 1998; 352:167-72.
    • (1998) Lancet , vol.352 , pp. 167-172
    • Sjöstron, L.1    Rissanen, A.2    Andersen, T.3
  • 20
    • 0033585499 scopus 로고    scopus 로고
    • Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial
    • Davidson M H, Hauptman J, DiGirolamo M et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. A randomized controlled trial. JAMA 1999; 281:235-42.
    • (1999) JAMA , vol.281 , pp. 235-242
    • Davidson, M.H.1    Hauptman, J.2    DiGirolamo, M.3
  • 21
    • 1042303480 scopus 로고    scopus 로고
    • Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • Torgerson JS, Hauptman J, Boldrin MN et al. Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-61
    • (2004) Diabetes Care , vol.27 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3
  • 22
    • 12744274872 scopus 로고    scopus 로고
    • Reduction of body weight and co-morbidities by orlistat: The XXL - Primary Health Care Trial
    • Wirth A. Reduction of body weight and co-morbidities by orlistat: The XXL - Primary Health Care Trial. Diab Obes Metab, 2005;7:21-7
    • (2005) Diab Obes Metab , vol.7 , pp. 21-27
    • Wirth, A.1
  • 23
    • 0026753155 scopus 로고
    • Beneficial health effects of modest weight loss
    • Goldstein D J. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;6: 397-415
    • (1992) Int J Obes Relat Metab Disord , vol.6 , pp. 397-415
    • Goldstein, D.J.1
  • 24
    • 12244289269 scopus 로고    scopus 로고
    • Pharmacological management of obesity
    • Hanif MW and Kumer S. Pharmacological management of obesity. Expert Opin Pharmacother 2002; 3:1711-8.
    • (2002) Expert Opin Pharmacother , vol.3 , pp. 1711-1718
    • Hanif, M.W.1    Kumer, S.2
  • 25
    • 17144382751 scopus 로고    scopus 로고
    • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
    • for the RIO-Europe Study Group
    • Van Gaal L, Rissanen AM, Scheen AK, for the RIO-Europe Study Group. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005; 365:1389-97
    • (2005) Lancet , vol.365 , pp. 1389-1397
    • Van Gaal, L.1    Rissanen, A.M.2    Scheen, A.K.3
  • 26
    • 0034516930 scopus 로고    scopus 로고
    • Effects of sibutramine on weight maintenance after weight loss: A randomized trial
    • for the STORM Study Group
    • James WPT, Astrup A, Finer N, for the STORM Study Group. Effects of sibutramine on weight maintenance after weight loss: a randomized trial. Lancet 2000; 356: 2119-25
    • (2000) Lancet , vol.356 , pp. 2119-2125
    • James, W.P.T.1    Astrup, A.2    Finer, N.3
  • 27
    • 0033629936 scopus 로고    scopus 로고
    • Weight loss, weight maintenance and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
    • Rössner S, Sjöstron L, Noack R et al. Weight loss, weight maintenance and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Obes Res 2000; 8: 49-61
    • (2000) Obes Res , vol.8 , pp. 49-61
    • Rössner, S.1    Sjöstron, L.2    Noack, R.3
  • 28
    • 0034621494 scopus 로고    scopus 로고
    • Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
    • Heymsfield SB, Segal K R, Hauptman J et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000; 160: 1321-6.
    • (2000) Arch Intern Med , vol.160 , pp. 1321-1326
    • Heymsfield, S.B.1    Segal, K.R.2    Hauptman, J.3
  • 29
    • 0031904104 scopus 로고    scopus 로고
    • Role of orlistat in the treatment of obese patients with type 2 diabetes
    • Hollander PA, Elbein S C. Hirsch IB et al. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 1998; 21: 1288-94
    • (1998) Diabetes Care , vol.21 , pp. 1288-1294
    • Hollander, P.A.1    Elbein, S.C.2    Hirsch, I.B.3
  • 30
    • 0028866609 scopus 로고
    • Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers
    • Zhi J, Melia AT, Eggers H, Joly R, Patel IH. Review of Limited Systemic Absorption of Orlistat, a Lipase Inhibitor, in Healthy Human Volunteers. Clin Pharmacol 1995;35:1103-1108
    • (1995) Clin Pharmacol , vol.35 , pp. 1103-1108
    • Zhi, J.1    Melia, A.T.2    Eggers, H.3    Joly, R.4    Patel, I.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.